NewAmsterdam Pharma Co NV (NAMS)
16.23
+0.40
(+2.53%)
USD |
NASDAQ |
Sep 27, 16:00
16.26
+0.04
(+0.22%)
After-Hours: 20:00
NewAmsterdam Pharma Cash from Operations (Quarterly): -53.98M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -53.98M |
March 31, 2024 | -54.60M |
Date | Value |
---|---|
June 30, 2023 | -29.30M |
March 31, 2023 | -31.86M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-54.60M
Minimum
Mar 2024
-29.30M
Maximum
Jun 2023
-42.44M
Average
-42.92M
Median
Cash from Operations (Quarterly) Benchmarks
Koninklijke Philips NV | -- |
uniQure NV | -32.71M |
ProQR Therapeutics NV | -6.593M |
Merus NV | 5.633M |
argenx SE | -124.66M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.209M |
Cash from Financing (Quarterly) | 4.658M |
Free Cash Flow | -170.36M |
Free Cash Flow Per Share (Quarterly) | -0.5721 |
Free Cash Flow to Equity (Quarterly) | -54.19M |
Free Cash Flow to Firm (Quarterly) | -54.19M |
Free Cash Flow Yield | -12.11% |